Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS • Currently down 0.36 (-4.51%) in today's trading session

Track congressional stock trades in Enanta Pharmaceuticals, Inc. (ENTA). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

Enanta Pharmaceuticals, Inc. is currently trading at $7.62, positioned at 1% of its 52-week range ($7.56 – $17.15).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$7.62
24h Change
-0.36 (-4.51%)
52 Week Range
$7.56–$17.15
View on NASDAQ

Enanta Pharmaceuticals, Inc. Price History and Technical Analysis

Congressional Trading Activity for ENTA

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$222.19M

Volume

457.63K

Beta

0.96

P/E Ratio

-3.16

Fundamentals

EPS

$-2.41

Div. Yield

-

Open

$7.82

Day Range

$7.56 – $7.99

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Jay R. Luly
IPO Date
2013-03-21

Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its research and development efforts are primarily focus...

Earnings

Next Report

Q4 2026

8 Feb

EPS Est.

$-0.63

Rev. Est.

$14.3M

Days Until

78

Recent Quarters

Q3 202616 Nov
EPS$-0.81
Miss 11.9%
Q2 202610 Aug
EPS$-0.67
Miss 31.5%
Q1 202611 May
EPS$-0.45
Beat 2.2%
Q4 20259 Feb
EPS$-0.42
Beat 22.2%
Q3 202517 Nov
EPS$-0.87
Beat 23.0%
Q2 202511 Aug
EPS$-0.85
Beat 32.0%
Q1 202512 May
EPS$-1.06
Miss 1.9%
Q4 202410 Feb
EPS$-1.05
Beat 9.5%
Q3 202425 Nov
EPS$-1.36
Miss 17.2%
Q2 20245 Aug
EPS$-1.07
Beat 28.2%
Q1 20246 May
EPS$-1.47
Miss 16.7%
Q4 20237 Feb
EPS$-1.58
Miss 33.9%
Q3 202320 Nov
EPS$-1.33
Beat 37.0%
Q2 20237 Aug
EPS$-1.86
Beat 21.9%
Q1 20238 May
EPS$-1.79
Beat 6.3%
Q4 20227 Feb
EPS$-1.39
Beat 8.6%
Q3 202221 Nov
EPS$-1.27
Beat 7.3%
Q2 20228 Aug
EPS$-1.53
Miss 12.5%
Q1 20229 May
EPS$-1.63
Miss 14.0%
Q4 20218 Feb
EPS$-1.48
Miss 31.0%
Q3 202122 Nov
EPS$-1.22
Beat 6.9%
Q2 20215 Aug
EPS$-1.19
Beat 15.6%
Q1 20216 May
EPS$-1.09
Miss 16.0%
Q4 20208 Feb
EPS$-0.41
Beat 50.0%
Q3 202023 Nov
EPS$-0.55
Beat 40.2%
Q2 20204 Aug
EPS$-0.71
Beat 2.7%
Q1 20206 May
EPS$-0.30
Beat 58.9%
Q4 20196 Feb
EPS$0.65
Beat 18.2%
Q3 201921 Nov
EPS$0.44
Miss 17.0%
Q2 20196 Aug
EPS$0.33
Beat 106.3%
Q1 20197 May
EPS$0.20
Beat 350.0%
Q4 20186 Feb
EPS$1.25
Miss 7.4%
Q3 201826 Nov
EPS$1.30
Beat 9.2%
Q2 20187 Aug
EPS$0.97
Miss 1.0%
Q1 20188 May
EPS$0.61
Beat 15.1%
Q4 20177 Feb
EPS$0.59
Beat 210.5%
Q3 201720 Nov
EPS$1.86
Miss 12.7%
Q2 20177 Aug
EPS$-0.44
Beat 10.2%
Q1 20178 May
EPS$-0.28
Beat 26.3%
Q4 20168 Feb
EPS$-0.26
Miss 73.3%
Q3 201621 Nov
EPS$-0.09
Beat 18.2%
Q2 20168 Aug
EPS$-0.06
Beat 53.9%
Q1 20169 May
EPS$-0.09
Miss 169.2%
Q4 20158 Feb
EPS$1.36
Beat 20.4%
Q3 201523 Nov
EPS$0.29
Beat 93.3%
Q2 20156 Aug
EPS$0.13
Miss 31.6%
Q1 20157 May
EPS$1.49
Miss 15.3%
Q4 20145 Feb
EPS$2.18
Miss 42.9%
Q3 201424 Nov
EPS$-0.27
Beat 18.2%
Q2 201411 Aug
EPS$1.81
Beat 9.7%
Q1 201412 May
EPS$-0.28
Miss 140.6%
Q4 201313 Feb
EPS$-0.30
Miss 11.1%
Q3 201325 Nov
EPS$-0.25
Miss 8.7%
Q2 201312 Aug
EPS$-0.23
Beat 30.3%
Q1 201315 May
EPS$-1.71
Q1 20138 May
EPS$-2.28
Miss 590.9%
Q2 201230 Sept
EPS$-3.50
Q1 201230 Jun
EPS$-1.33
Q4 201131 Mar
EPS$12.18
Q3 201131 Dec
EPS$-0.22
Q2 201130 Sept
EPS$-0.31

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.